TrueBlue (TBI) Tops Q2 EPS by 28c
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $10.23 --0%
Financial Fact:
Depreciation and amortization: 11.69M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Depreciation and amortization: 11.69M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
TrueBlue (NYSE: TBI) reported Q2 EPS of $0.82, $0.28 better than the analyst estimate of $0.54. Revenue for the quarter came in at $569 million versus the consensus estimate of $572.77 million.
For earnings history and earnings-related data on TrueBlue (TBI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
- Traws Pharma (TRAW) Tops Q2 EPS by 27c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
